Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum

Title: Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum
Authors: Ljungman, Per; Chemaly, Roy F; Khawaya, Fareed; Alain, Sophie; Avery, Robin; Badshah, Cyrus; Boeckh, Michael; Fournier, Martha; Hodowanec, Aimee; Komatsu, Takashi; Limaye, Ajit P; Manuel, Oriol; Natori, Yoichiro; Navarro, David; Pikis, Andreas; Razonable, Raymund R; Westman, Gabriel; Miller, Veronica; Griffiths, Paul D; Kotton, Camille N; Piki, Andreas; Caliendo, Angie; Chou, Sunwen; Humar, Atul; Randhawa, Parmjeet; Slavin, Monica; Wong, Michelle; Wolf, Dana
Contributors: Forum; AiCuris; AlloVir; Evrys Bio; HHV-6 Foundation; Merck; Takeda; Symbio; Qiagen; Vera Therapeutics; Eurofins Viracor
Source: Clinical Infectious Diseases ; volume 79, issue 3, page 787-794 ; ISSN 1058-4838 1537-6591
Publisher Information: Oxford University Press (OUP)
Publication Year: 2024
Description: Cytomegalovirus (CMV) infection and disease are important causes of morbidity and mortality in transplant recipients. For the purpose of developing consistent reporting of CMV outcomes in clinical trials, definitions of CMV infection and disease were developed and most recently published in 2017. Since then, there have been major developments, including registration of new antiviral agents. Therefore, the Transplant Associated Virus Infections Forum, which consists of scientists, clinicians, regulators, and industry representatives, has produced an updated version of these definitions that incorporates recent knowledge with the aim of supporting clinical research and drug development. This also includes an update regarding the definition of resistant and refractory CMV infections previously published in 2019. As the field evolves, the need for updates of these definitions is clear, and collaborative efforts among clinicians, scientists, regulators, and industry representatives can provide a platform for this work.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1093/cid/ciae321
DOI: 10.1093/cid/ciae321/58616941/ciae321.pdf
Availability: https://doi.org/10.1093/cid/ciae321; https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae321/58616941/ciae321.pdf; https://academic.oup.com/cid/article-pdf/79/3/787/59357038/ciae321.pdf
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.99AC0FF9
Database: BASE